Literature DB >> 19051807

Accuracy of frozen section diagnosis at surgery in pre- malignant and malignant lesions of the endometrium.

S Attard Montalto1, M Coutts, O Devaja, J Summers, R Jyothirmayi, A Papadopoulos.   

Abstract

OBJECTIVE: The purpose of this study was to correlate the histological diagnosis made during intraoperative frozen section examination of hysterectomies with atypical hyperplasia or carcinoma, with the definitive paraffin section histology. STUDY
DESIGN: Frozen section pathology results of patients with a preoperative biopsy showing atypical hyperplasia or endometrial carcinoma (87 patients) were compared retrospectively with paraffin section pathology findings. Those patients with curettage specimens showing atypical hyperplasia or curettings suspicious of endometrioid carcinoma had intraoperative frozen section to determine whether an invasive lesion was present and whether they required pelvic lymphadenectomy. The purpose of frozen section assessment in those patients who had a preoperative curettage specimen showing endometrial carcinoma was to identify poor prognostic pathological factors related to histological subtype, grade, depth of myometrial invasion and cervical involvement.
RESULTS: The correlation between frozen sections and paraffin histology in patients with endometrial carcinoma was 98.6% (69/70) for histological sub-type and 84.3% (59/70) for grade of differentiation. Depth of myometrial invasion was accurately diagnosed in 94.3% (66/70) while cervical involvement was accurately assessed in 86.7% (52/60). Of the 37 patients with atypical hyperplasia or suspicious curettings on preoperative curettage who had intraoperative frozen section, 23 patients had invasive malignancy, which was confirmed in subsequent paraffin sections. Of the remaining 14 patients with a non-malignant frozen section diagnosis, 11 were confirmed with paraffin sections while three had a small well differentiated invasive lesion, two were FIGO Stage 1a and one had microscopic invasion into the myometrium.
CONCLUSION: Intraoperative frozen section is a useful procedure to identify poor prognostic pathological factors as well as to diagnose endometrial cancer in patients undergoing hysterectomy for a preoperative biopsy diagnosis of atypical hyperplasia.

Entities:  

Mesh:

Year:  2008        PMID: 19051807

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  6 in total

1.  Prediction of staging with preoperative parameters and frozen/section in patients with a preoperative diagnosis of grade 1 endometrioid tumor in endometrial cancer.

Authors:  Alper Karalok; Işın Ureyen; Yıldız Reis; Ozge Oktay; Taner Turan; Nurettin Boran; Dilek Bülbül; Gökhan Tulunay; Mehmet Faruk Köse
Journal:  J Turk Ger Gynecol Assoc       Date:  2014-01-30

Review 2.  Management of endometrial precancers.

Authors:  Cornelia L Trimble; Michael Method; Mario Leitao; Karen Lu; Olga Ioffe; Moss Hampton; Robert Higgins; Richard Zaino; George L Mutter
Journal:  Obstet Gynecol       Date:  2012-11       Impact factor: 7.661

3.  Systemic lymphadenectomy cannot be recommended for low-risk corpus cancer.

Authors:  Takao Hidaka; Akitoshi Nakashima; Tomoko Shima; Toru Hasegawa; Shigeru Saito
Journal:  Obstet Gynecol Int       Date:  2010-02-04

4.  The role of frozen section in surgical staging of low risk endometrial cancer.

Authors:  Sanjeev Kumar; Sudeshna Bandyopadhyay; Assaad Semaan; Jay P Shah; Haider Mahdi; Robert Morris; Adnan Munkarah; Rouba Ali-Fehmi
Journal:  PLoS One       Date:  2011-09-01       Impact factor: 3.240

Review 5.  Endometrial hyperplasia as a risk factor of endometrial cancer.

Authors:  Lisa K Nees; Sabine Heublein; Sahra Steinmacher; Ingolf Juhasz-Böss; Sara Brucker; Clemens B Tempfer; Markus Wallwiener
Journal:  Arch Gynecol Obstet       Date:  2022-01-10       Impact factor: 2.493

6.  Is routine frozen section analysis necessary in patients with non-endometrioid cancer or grade 3 endometrioid cancer?

Authors:  Qingyong Guo; Huan Yi; Xiaodan Chen; Jianrong Song; Lingsi Chen; Xiangqin Zheng
Journal:  Int J Gynaecol Obstet       Date:  2021-05-12       Impact factor: 4.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.